HK1198127A1 - Stable dosage forms of arterolane and piperaquine - Google Patents
Stable dosage forms of arterolane and piperaquine Download PDFInfo
- Publication number
- HK1198127A1 HK1198127A1 HK14111655.7A HK14111655A HK1198127A1 HK 1198127 A1 HK1198127 A1 HK 1198127A1 HK 14111655 A HK14111655 A HK 14111655A HK 1198127 A1 HK1198127 A1 HK 1198127A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- arterolane
- piperaquine
- dosage forms
- stable dosage
- stable
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/183,119 US8664265B2 (en) | 2005-05-18 | 2011-07-14 | Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials |
| US201113183119 | 2011-07-14 | ||
| IN2703DE2011 | 2011-09-19 | ||
| INDE27032011 | 2011-09-19 | ||
| INDE21562012 | 2012-07-12 | ||
| IN2156DE2012 | 2012-07-12 | ||
| PCT/IB2012/053614 WO2013008218A1 (en) | 2011-07-14 | 2012-07-13 | Stable dosage forms of arterolane and piperaquine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1198127A1 true HK1198127A1 (en) | 2015-03-13 |
Family
ID=52630024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK14111655.7A HK1198127A1 (en) | 2011-07-14 | 2012-07-13 | Stable dosage forms of arterolane and piperaquine |
Country Status (3)
| Country | Link |
|---|---|
| BR (1) | BR112014000935A2 (en) |
| HK (1) | HK1198127A1 (en) |
| ZA (1) | ZA201405276B (en) |
-
2012
- 2012-07-13 HK HK14111655.7A patent/HK1198127A1/en unknown
- 2012-07-13 BR BR112014000935A patent/BR112014000935A2/en not_active IP Right Cessation
-
2014
- 2014-07-14 ZA ZA2014/05276A patent/ZA201405276B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA201405276B (en) | 2016-02-24 |
| BR112014000935A2 (en) | 2017-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3406608B8 (en) | Therapeutically active compounds and their methods of use | |
| EP2665508A2 (en) | Blockstent device and methods of use | |
| EP2536283B8 (en) | Phenyl-heteroaryl derivatives and methods of use thereof | |
| EP2663312A1 (en) | Irak inhibitors and uses thereof | |
| EP2678018A4 (en) | Combination of kanase inhibitors and uses thereof | |
| EP3415139B8 (en) | Administration of benzodiazepine | |
| ZA201401117B (en) | Kynurenine-3-monooxygenase inhibitors,pharmaceutical compositions,and methods of use thereof | |
| IL253911A0 (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| IL230705A0 (en) | Certain kynurenine-3-monooxygenase inhibitors,pharmaceutical compositions,and methods of use thereof | |
| EP2734513A4 (en) | An intermediate of statin drugs and preparation thereof | |
| EP2671176A1 (en) | Preventing over-delivery of drug | |
| AP2014007413A0 (en) | Stable dosage forms of arterolane and piperaquine | |
| EP2536688A4 (en) | Stable dosage forms of levomilnacipran | |
| HK1198127A1 (en) | Stable dosage forms of arterolane and piperaquine | |
| HK1192727A (en) | Combination of kanase inhibitors and uses thereof | |
| HK1188494A (en) | Preventing over-delivery of drug | |
| HK1191950A (en) | Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof | |
| AU2011903137A0 (en) | Compounds and methods of their use - IV | |
| AU2011904672A0 (en) | Therapeutic Compounds and Uses Thereof | |
| HK1193417A (en) | Anti-fgfr4 antibodies and methods of use | |
| HK1201463B (en) | Cd40l-specific tn3-derived scaffolds and methods of use thereof | |
| HK1191009A (en) | Solid forms and salts of tetrahydro-pyrido-pyrimidine derivatives | |
| AU2011900644A0 (en) | Therapeutic Uses of SLIRP | |
| AU2011902559A0 (en) | Compounds and Therapeutic Applications Therefor | |
| AU2011901049A0 (en) | Catalysts and Methods of Use |